Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer

• Hong Zheng ,

  Contributed equally to this work with: Hong Zheng, Lina Zhang

  Affiliations Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, P.R. China

  ⨯
• Lina Zhang ,

  Contributed equally to this work with: Hong Zheng, Lina Zhang

  Affiliations Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, P.R. China, Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China

  ⨯
• Yanrui Zhao,

  Affiliations Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, P.R. China

  ⨯
• Da Yang,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Fengju Song,

  Affiliations Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, P.R. China

  ⨯
• Yang Wen,

  Affiliation Key Laboratory of Reproductive Medicine, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Quan Hao,

  Affiliations Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, P.R. China, Department of Gynaecological Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China

  ⨯
• Zhibin Hu,

  Affiliation Key Laboratory of Reproductive Medicine, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Wei Zhang ,

  * E-mail: wzhang@mdanderson.org (WZ); chenkexin1963@yahoo.com (KC)

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Kexin Chen

  * E-mail: wzhang@mdanderson.org (WZ); chenkexin1963@yahoo.com (KC)

  Affiliations Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, P.R. China

  ⨯